Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Karen Barrett"'
Publikováno v:
Cogent Education. 9
Autor:
Solange Peters, Hisani Madison, Kelly Oliner, Anne L’Hernault, Marianne Ratcliffe, Karen Barrett, Xiaojin Shi, Edward B. Garon, Tony Mok, Melissa L. Johnson
Publikováno v:
Cancer Research. 83:CT080-CT080
Background: In the Phase 3 POSEIDON study (NCT03164616), 1L T plus D and platinum-based CT demonstrated statistically significant improvements in both PFS (HR, 0.72; 95% CI, 0.60-0.86; p=0.0003; data cutoff [DCO] July 24, 2019) and OS (HR, 0.77; 95%
Publikováno v:
INTED2022 Proceedings.
Publikováno v:
RUA. Repositorio Institucional de la Universidad de Alicante
Universidad de Alicante (UA)
Journal of New Approaches in Educational Research, Vol 11, Iss 1, Pp 146-166 (2022)
Universidad de Alicante (UA)
Journal of New Approaches in Educational Research, Vol 11, Iss 1, Pp 146-166 (2022)
Precise assessment of school readiness is critical because it has practical and theoretical implications for children’s school and life success. However, school readiness assessment mainly relies on teacher reports and a few direct evaluations requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd5e70a720fdc0395cd15ef2fed04f4
http://hdl.handle.net/10045/120903
http://hdl.handle.net/10045/120903
Autor:
Byoung Chul Cho, Niels Reinmuth, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Dmytro Trukhin, Sang-We Kim, Grygorii Ursol, Maen A. Hussein, Farah Louise Lim, Cheng-Ta Yang, Luiz H. Araujo, Haruhiro Saito, Miriam Marotti, Karen Barrett, Xiaojin Shi, Solange Peters, Edward B. Garon, Tony S. K. Mok, Melissa Lynne Johnson
Publikováno v:
Journal of Clinical Oncology. 40:9035-9035
9035 Background: In the Phase 3 POSEIDON study in 1L mNSCLC, adding T to D+CT resulted in statistically significant improvements in PFS and OS vs CT. No new safety signals were identified and treatment discontinuations due to treatment-related AEs (T
Publikováno v:
Journal of Crohn'scolitis. 14(9)
Background and Aims Patients with ulcerative colitis [UC] require rapid and complete relief of symptoms, particularly stool frequency and rectal bleeding. The aim of this study was to determine time to symptom resolution in patients with UC during in
Autor:
Jerrold R. Turner, G. De Hertogh, Karen Barrett, Toer W. Stevens, David T. Rubin, Krisztina B Gecse, G R D’Haens
Publikováno v:
Journal of Crohn's and Colitis. 13:S169-S169
Autor:
Mary Palmen, Michael Safdi, Sunanda V. Kane, Dory Solomon, Seymour Katz, Mph M. Mazen Jamal Md, Ben Dolin, Karen Barrett
Publikováno v:
Inflammatory Bowel Diseases. 18:1026-1033
Background: This was a phase IV, multicenter, open-label, 12–14-month study to assess clinical recurrence in patients with ulcerative colitis (UC) who received maintenance treatment with MMX Multi Matrix System (MMX) mesalamine. A secondary outcome
Publikováno v:
American journal of gastroenterology, 107(7), 1064-1077. Springer Nature
Objectives Treatment with mesalamine to maintain endoscopic remission (mucosal healing) of ulcerative colitis (UC) has been shown to reduce the risk of relapse and is the recommended first-line maintenance therapy. To improve treatment adherence, a m
Publikováno v:
European Journal of Oncology Nursing. 15:112-117
Purpose of the study In order to improve ‘adherence’ to a course of treatment for head and neck radiotherapy, patients need to be managed frequently. In order to achieve this in a busy clinical environment streamlined electronic tools must be uti